Table 1.

Simulated Phase I trial of complete information for a sample of 20 patients under an assumed set of true DLT probabilities.

Patient	Tolerance	True DLT probability at dose level i
j	vj	0.05	0.07	0.20	0.35	0.55	0.70
1	0.606	0	0	0	0	0	1
2	0.703	0	0	0	0	0	0
3	0.891	0	0	0	0	0	0
4	0.441	0	0	0	0	1	1
5	0.115	0	0	1	1	1	1
6	0.247	0	0	0	1	1	1
7	0.686	0	0	0	0	0	1
8	0.968	0	0	0	0	0	0
9	0.967	0	0	0	0	0	0
10	0.464	0	0	0	0	1	1
11	0.958	0	0	0	0	0	0
12	0.441	0	0	0	0	1	1
13	0.008	1	1	1	1	1	1
14	0.843	0	0	0	0	0	0
15	0.221	0	0	0	1	1	1
16	0.500	0	0	0	0	1	1
17	0.294	0	0	0	1	1	1
18	0.143	0	0	1	1	1	1
19	0.671	0	0	0	0	0	1
20	0.506	0	0	0	0	1	1
Sample Proportions		0.05	0.05	0.15	0.30	0.55	0.70